CD274 and prostate carcinoma: Additionally, MSeA has been found to suppress IFN-γ-induced programmed death-ligand 1 (PD-L1) expression in prostate cancer, which can reverse PD-1/PD-L1 inhibitor resistance induced by cisplatin [144].